The FDA granted a record nine review designations to mRNA vaccines in 2023, reflecting a growing commitment to this innovative technology.

South African biopharmaceutical manufacturer, Biovac, has announced a new manufacturing partnership with global biopharmaceutical company, Sanofi, as...

Vaccinating children ages 5–11 is critical to slowing the spread of COVID-19 in the U.S. and globally. Parents may have questions about getting...

TUESDAY, July 2, 2024 -- U.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a...

As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to...

Moderna (MRNA) stock sinks after new data shows the efficacy of its mRNA-based RSV vaccine fell sharply in the second year and was lower than that of...

While a vaccine exists to prevent human papillomavirus (HPV), the main cause of cervical cancer, over 20 therapeutic HPV vaccine candidates are...

US Biomedical Advanced Research and Development Authority funds will be used to complete the development and testing of a mRNA-based vaccine for bird...

Six months before the first jabs arrived, an online survey in January of 2021 showed that nearly 60% of the 7 193 respondents were confident in a...

A prominent American cardiologist called for courage at a conference of Canadian patriots, urging attendees to share their concerns about mRNA...